Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure

PaperCitations, authors & open-access status

Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 36 citations, 2009 year and closed oa status.

36
Citations
2009
Year
closed
OA Status

Related on ScholarIQ

Adrian Kielhorn
Author
The European Journal of Health Economics
Journal
Rheumatoid Arthritis Research and Therapies
Topic
Rheumatoid Arthritis Research and Therapies
Topic
Biosimilars and Bioanalytical Methods
Topic
Autoimmune and Inflammatory Disorders Research
Topic
470M+ articles · free account